Surgical matrices revenue is flat while procedure volumes level out
With elective procedures in the United States mostly back at pre-pandemic levels, the US Surgical Matrices Market returned to what had been normal growth according to SmartTRAK Financial Dashboard. Becton Dickinson* (BD) grew to a 26.9% share, while AbbVie* slipped to second place.
Among the many topics covered in detail in our comprehensive Q222 US Surgical Matrices Market Recap* are:
- Complete Q222 US Surgical Matrices Market Overview and Highlights
- SmartTRAK's Expert Analysis and Insights
- All Company News, Revenues, Data, Charts and Shares
- Top Players’ Results
- US Surgical Matrices Market Returns To Normal
- US Breast Matrices: Revenues Flat As Procedures Stabilize
- US Hernia Repair Matrices Market: A Solid Quarter
- Important Q222 Clinical & Regulatory Events
Taking over first place, BD grew revenues to a +6.2% YoY gain. while AbbVie lost its dominance in Surgical Matrices as it struggled with supply chain issues. JNJ/Ethicon held steady in third place, despite ...
Read the entire Q222 US Surgical Matrices Market Recap, including SmartTRAK's expert analysis, news, data, charts, company revenues and shares*
*The entire unedited article and these links can only be viewed by SmartTRAK subscribers to this module. For more information on SmartTRAK, including how to receive a demo and subscribe, please click the button below.
SmartTRAK is a comprehensive, easy-to-use, business intelligence solution for the Life Sciences Industry that provides breaking updates on pertinent company news, potential treatments and guidance, international survey results, statistical analysis by country, studies, trial results, financial impact and more. All subscribers receive a Daily Updates email containing the latest need-to-know news curated by our expert analysts. It's the perfect way to start your day! If you would like to learn more about SmartTRAK, just click
here.